AtriCure, Inc. (NASDAQ:ATRC) Q2 2025 Earnings Conference Call July 29, 2025 4:30 PM ET
Company Participants
Angela L. Wirick – Chief Financial Officer
Michael H. Carrel – CEO, President & Director
Conference Call Participants
Daniel Walker Stauder – Citizens JMP Securities, LLC, Research Division
Danielle Joy Antalffy – UBS Investment Bank, Research Division
John Glenn McAulay – Stifel, Nicolaus & Company, Incorporated, Research Division
Lilia-Celine Breton Lozada – JPMorgan Chase & Co, Research Division
Marie Yoko Thibault – BTIG, LLC, Research Division
Suraj Kalia – Oppenheimer & Co. Inc., Research Division
Marissa Elizabeth Bych – Gilmartin Group LLC
Operator
Good afternoon, and welcome to AtriCure’s Second Quarter 2025 Earnings Conference Call. This call is being recorded for replay purposes.
[Operator Instructions]
I would now like to turn the call over to Marissa Bych from Gilmartin Group for a few introductory comments.
Marissa Elizabeth Bych
Thank you. By now, you should have received a copy of the earnings press release. If you have not received a copy, please call (513)-644-4484 to have one e-mailed to you. Before we begin today, let me remind you that the company’s remarks include forward- looking statements. Forward-looking statements are subject to numerous risks and uncertainties, many of which are beyond AtriCure’s control, including risks and uncertainties described from time to time in AtriCure’s SEC filings.
These statements include, but are not limited to, financial expectations and guidance, expectations regarding the potential market opportunity for AtriCure’s franchises and growth initiatives, future product approvals and clearances, competition, reimbursement and clinical trial outcomes.
AtriCure’s results may differ materially from those projected. AtriCure undertakes no obligation to publicly update any forward- looking statement. Additionally, we refer to non-GAAP financial measures, specifically constant currency revenue, adjusted EBITDA and adjusted loss per share. A reconciliation of these non-GAAP financial measures with the most directly comparable GAAP measures is
#AtriCure #ATRC #Earnings #Call #Transcript